Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up. (Q46052290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

malignant pheochromocytoma

1 reference

1

Kebebew E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

2

Duh QY

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

Surgical oncology clinics of North America

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

765-789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

The triad of gastric epithelioid leiomyosarcoma, pulmonary chondroma, and functioning extra-adrenal paraganglioma: a five-year review.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Laparoscopic adrenalectomy. Comparison of the lateral and posterior approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Integrated imaging of adrenal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Is laparoscopic adrenalectomy indicated for pheochromocytomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Laboratory diagnosis of phaeochromocytoma: which analytes should we measure?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Use of laparoscopic techniques improves outcome from adrenalectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Risk factors for adrenal cancer: an exploratory study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Pheochromocytoma. Lateral versus anterior operative approach

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

1 reference

7 January 2021

Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Somatostatin-receptor imaging in the localization of endocrine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Tumor angiogenesis in pheochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Malignant pheochromocytoma: clinical course and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

The role of radiolabeled somatostatin analogs in adrenal imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Management of adrenal neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

"The" pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Recent developments in the diagnosis and treatment of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

High-voltage irradiation and combination chemotherapy for malignant pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Adrenalectomy in the era of laparoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Laparoscopic adrenalectomy: clinical experience with 12 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Malignant pheochromocytoma, still a therapeutic challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s)

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Pheochromocytoma. Update on diagnosis, localization, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Early surgical history of phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930244-8

7 January 2021

10.1016/S1055-3207(18)30244-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9735133%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference